Browsing Category

33472 posts
PayJoy Marks 10 Years and 15 Million Customers: Focused on Expanding Responsible Financing in Emerging Markets

PayJoy Marks 10 Years and 15 Million Customers: Focused on Expanding Responsible Financing in Emerging Markets

SAN FRANCISCO, June 4, 2025 /PRNewswire/ — PayJoy, a Public Benefit Corporation…
H World Group Releases 2024 Sustainability Report, Advancing Sustainable Development through Service Innovation and Green Operations

H World Group Releases 2024 Sustainability Report, Advancing Sustainable Development through Service Innovation and Green Operations

SHANGHAI, June 3, 2025 /PRNewswire/ — H World Group Limited (NASDAQ:HTHT) (HK:01179),…

ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis

TOKYO, June 3, 2025 /PRNewswire/ — ThinkCyte, a life science company pioneering…
Sipping Tea while Enjoying Opera: The 2025 Beijing Chaoyang International Tea Culture Week Showcases Cultural Charm

Sipping Tea while Enjoying Opera: The 2025 Beijing Chaoyang International Tea Culture Week Showcases Cultural Charm

BEIJING, CHINA – Media OutReach Newswire – 3 June 2025 – On…
Luxren Capital Introduces a New Era in Mobile Trading: Secure, Regulated, and Always at Users' Fingertips

Luxren Capital Introduces a New Era in Mobile Trading: Secure, Regulated, and Always at Users' Fingertips

Port Louis, Mauritius, June 3, 2025 – (ACN Newswire) – As more and…

Schneider Electric, Siemens AG, and GE Vernova Take Top Spots in ABI Research's Energy Grid Digitalization Technologies Competitive Ranking

LONDON, June 3, 2025 /PRNewswire/ — A new Competitive Ranking by global…
Hyundai Motor Company President and CEO José Muñoz Reinforces Hyundai's Journey as a Mobility Leader at FISITA World Mobility Conference 2025

Hyundai Motor Company President and CEO José Muñoz Reinforces Hyundai's Journey as a Mobility Leader at FISITA World Mobility Conference 2025

Hyundai Motor Group showcases its future mobility vision and technology innovations at…
Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach

Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach

Phase IIa study results of Rentosertib were published simultaneously in Nature Medicine(IF =…